{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:25:30Z","timestamp":1792041930251,"version":"4.4.0"},"reference-count":64,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Pulmonary hypertension is a debilitating condition that frequently develops in the setting of interstitial lung disease, likely related to chronic alveolar hypoxemia and pulmonary vascular remodeling. This disease process is likely to be identified more frequently by providers given recent advancements in definitions and diagnostic modalities, and provides practitioners with emerging opportunities to improve patient outcomes and quality of life. Despite years of data suggesting against the efficacy of pulmonary vasodilator therapy in patients with pulmonary hypertension due to interstitial lung disease, new data have emerged identifying promising advancements in therapeutics. The authors present to you a comprehensive review of pulmonary hypertension in interstitial lung disease, reviewing our current understanding of pathophysiology, updates in diagnostic approaches, and highlights of recent clinical trials which provide an effective approach for medical management.<\/jats:p>","DOI":"10.3390\/cells12192394","type":"journal-article","created":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T16:58:09Z","timestamp":1696179489000},"page":"2394","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics"],"prefix":"10.3390","volume":"12","author":[{"given":"Zachary A.","family":"Haynes","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu","family":"Chandel","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"King","sequence":"additional","affiliation":[{"name":"Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Fairfax, VA 22031, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1164\/rccm.201712-2405LE","article-title":"Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension","volume":"197","author":"Prins","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e003973","DOI":"10.1161\/CIRCOUTCOMES.117.003973","article-title":"Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada","volume":"11","author":"Wijeratne","year":"2018","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1802148","DOI":"10.1183\/13993003.02148-2018","article-title":"An overview of the 6th World Symposium on Pulmonary Hypertension","volume":"53","author":"McLaughlin","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","article-title":"Comorbidities in idiopathic pulmonary fibrosis patients: A systematic literature review","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000114246","article-title":"Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"76","author":"Nathan","year":"2008","journal-title":"Respiration"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1801914","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1183\/09031936.00010414","article-title":"A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis","volume":"44","author":"Oliveira","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1800545","DOI":"10.1183\/13993003.00545-2018","article-title":"Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia","volume":"52","author":"King","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccl.2016.04.003","article-title":"Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and Treatments","volume":"34","author":"Klinger","year":"2016","journal-title":"Cardiol. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hoeper, M.M., Behr, J., Held, M., Grunig, E., Vizza, C.D., Vonk-Noordegraaf, A., Lange, T.J., Claussen, M., Groh\u00e9, C., and Klose, H. (2015). Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141911"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00441-016-2539-y","article-title":"Pulmonary vascular remodeling in pulmonary hypertension","volume":"367","author":"Tuder","year":"2017","journal-title":"Cell Tissue Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.00015608","article-title":"Pulmonary hypertension in COPD","volume":"32","author":"Chaouat","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.chest.2020.04.046","article-title":"The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment","volume":"158","author":"King","year":"2020","journal-title":"Chest"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1164\/rccm.200608-1153CC","article-title":"Idiopathic pulmonary fibrosis and pulmonary hypertension: Connecting the dots","volume":"175","author":"Nathan","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_19","first-page":"7","article-title":"Pulmonary hypertension in idiopathic pulmonary fibrosis: A review","volume":"26","author":"Corte","year":"2009","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/MCP.0000000000000190","article-title":"Practical considerations in the pharmacologic treatment of idiopathic pulmonary fibrosis","volume":"21","author":"King","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMra2207410","article-title":"Right Ventricular Failure","volume":"388","author":"Houston","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI115659","article-title":"Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms","volume":"89","author":"Bristow","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1378\/chest.06-1466","article-title":"Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis","volume":"131","author":"Hamada","year":"2007","journal-title":"Chest"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2019.01.035","article-title":"A Prospective Evaluation of the Diagnostic Accuracy of the Physical Examination for Pulmonary Hypertension","volume":"155","author":"Braganza","year":"2019","journal-title":"Chest"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chest.2022.02.012","article-title":"Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study","volume":"162","author":"Rahaghi","year":"2022","journal-title":"Chest"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/resp.13066","article-title":"CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis","volume":"22","author":"Yagi","year":"2017","journal-title":"Respirology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chest.2019.06.033","article-title":"Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung Disease","volume":"157","author":"Bax","year":"2020","journal-title":"Chest"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.rmed.2012.09.003","article-title":"Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease","volume":"106","author":"Andersen","year":"2012","journal-title":"Respir. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1378\/chest.06-2485","article-title":"Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis","volume":"131","author":"Nathan","year":"2007","journal-title":"Chest"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.healun.2018.09.011","article-title":"Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide","volume":"38","author":"Rose","year":"2019","journal-title":"J. Heart. Lung Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.rmed.2006.02.004","article-title":"The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis","volume":"100","author":"Lettieri","year":"2006","journal-title":"Respir. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1440-1843.2010.01877.x","article-title":"Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"16","author":"Swigris","year":"2011","journal-title":"Respirology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2008.03.022","article-title":"Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"102","author":"Nathan","year":"2008","journal-title":"Respir. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e011464","DOI":"10.1161\/JAHA.118.011464","article-title":"Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease","volume":"8","author":"Prins","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/crj.12608","article-title":"Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation","volume":"12","author":"Nowak","year":"2018","journal-title":"Clin. Respir. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/resp.13250","article-title":"Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization","volume":"23","author":"Keir","year":"2018","journal-title":"Respirology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/2045-8932.97598","article-title":"Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction","volume":"2","author":"Perez","year":"2012","journal-title":"Pulm. Circ."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/690017","article-title":"Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: A systematic review and meta-analysis","volume":"7","author":"Prins","year":"2017","journal-title":"Pulm. Circ."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(02)11024-5","article-title":"Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial","volume":"360","author":"Ghofrani","year":"2002","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2006.06.007","article-title":"Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics","volume":"38","author":"Colombat","year":"2007","journal-title":"Hum. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1183\/09031936.00024113","article-title":"Treatment of pulmonary hypertension in interstitial lung disease: Do not throw out the baby with the bath water","volume":"41","author":"Cottin","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201403-0446OC","article-title":"Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia","volume":"190","author":"Corte","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","article-title":"Treatment of idiopathic pulmonary fibrosis with ambrisentan: A parallel, randomized trial","volume":"158","author":"Raghu","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1702596","DOI":"10.1183\/13993003.02596-2017","article-title":"The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"51","author":"Cottin","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.200705-732OC","article-title":"BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"177","author":"King","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/rccm.201011-1874OC","article-title":"BUILD-3: A randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"184","author":"King","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1183\/09031936.00213911","article-title":"Riociguat for interstitial lung disease and pulmonary hypertension: A pilot trial","volume":"41","author":"Hoeper","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S2213-2600(19)30250-4","article-title":"Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): A randomised, placebo-controlled phase 2b study","volume":"7","author":"Nathan","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Zisman","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2213-2600(20)30356-8","article-title":"Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1164\/rccm.201908-1510ED","article-title":"Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. Echoes of the Past, Lessons for the Future","volume":"200","author":"Nathan","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"102128","DOI":"10.1016\/j.pupt.2022.102128","article-title":"Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis","volume":"73-74","author":"Pitre","year":"2022","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S2213-2600(21)00165-X","article-title":"Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: A post-hoc analysis of the INCREASE study","volume":"9","author":"Nathan","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.14797\/ZKUT3813","article-title":"Management of Pulmonary Hypertension Due to Chronic Lung Disease","volume":"17","author":"Sugarman","year":"2021","journal-title":"Methodist. Debakey Cardiovasc. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.healun.2018.03.010","article-title":"Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL","volume":"37","author":"Farber","year":"2018","journal-title":"J. Heart Lung Transplant."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Hoeper","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2002258","DOI":"10.1183\/13993003.02258-2020","article-title":"Sleep-related breathing disorders and pulmonary hypertension","volume":"57","author":"Adir","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_60","first-page":"PA522","article-title":"Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: Evaluation of clinical outcomes, adherence and safety","volume":"54","author":"Moth","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Wieteska-Mi\u0142ek, M., Szmit, S., Florczyk, M., Ku\u015bmierczyk-Droszcz, B., Ryczek, R., and Kurzyna, M. (2021). COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination. Vaccines, 9.","DOI":"10.3390\/vaccines9121395"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014\u2014An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation","volume":"34","author":"Weill","year":"2015","journal-title":"J. Heart Lung Transplant."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/19\/2394\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:03:50Z","timestamp":1760130230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/19\/2394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":64,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["cells12192394"],"URL":"https:\/\/doi.org\/10.3390\/cells12192394","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,1]]}}}